The Winter 2017 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and testing new treatments for squamous cell lung cancer.

The newsletter has the latest on a reopened sub-study, a trial update at the World Conference on Lung Cancer last month in Japan, and a December 7 webinar for site staff, who can get the study status and all their questions answered by Lung-MAP leaders on the call. Read the new edition here.

Other Recent Stories

SWOG Front Line banner
Mar 28, 2025
27 editions of our flagship training course = huge impact
SWOG Front Line banner
Mar 21, 2025
The S2212 de-escalation trial asks important questions the NCI's NCTN is uniquely qualified to answer
Team Hope rides for the ESITC
Mar 19, 2025
GU investigator Dr. Parminder Singh leads second team to tackle the Tour de Scottsdale.